Cyclo Therapeutics Stock (NASDAQ: CYTH) stock price, news, charts, stock research, profile.
You can purchase shares of Cyclo Therapeutics (NASDAQ:CYTH) through any online brokerage.
Other companies in Cyclo Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), HOOKIPA Pharma (NASDAQ:HOOK), OncoCyte (NASDAQ:OCX), Curis (NASDAQ:CRIS) and Evaxion Biotech (NASDAQ:EVAX).
Cyclo Therapeutics has a consensus price target of $0.95.
The stock price for Cyclo Therapeutics (NASDAQ: CYTH) is $0.8471 last updated January 24, 2025 at 5:11 PM EST.
There are no upcoming dividends for Cyclo Therapeutics.
Cyclo Therapeutics’s Q4 earnings are confirmed for Monday, March 17, 2025.
There is no upcoming split for Cyclo Therapeutics.
Cyclo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.